Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
暂无分享,去创建一个
M. Baccarani | P. Piccaluga | G. Martinelli | E. Ottaviani | S. Tura | S. Buonamici | F. Bonifazi | N. Testoni | G. Visani | V. Montefusco | C. Terragna | M. Amabile | M. Malagola | A. Isidori | D. Ruggeri